silevertinib in combination with temozolomide
BDTX-1535-201
Phase 2 small_molecule active
Quick answer
silevertinib in combination with temozolomide for Glioblastoma (GBM) is a Phase 2 program (small_molecule) at Black Diamond Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Black Diamond Therapeutics
- Indication
- Glioblastoma (GBM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active